We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| China Med | LSE:CMDS | London | Ordinary Share | SG9999002489 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 57.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
China Medstar Limited (the "Company")
Statement re: Possible Offer
The Board of the Company (the "Board") today confirms it has entered into
discussions with a third party which may or may not lead to an offer to acquire
the entire issued share capital of the Company at a price of 62 pence in cash
per ordinary share. Discussions are still deemed by the Board to be at an early
stage and therefore there can be no guarantee that any offer may materialise.
This announcement has been released with the permission of the third party.
Shareholders are reminded that the City Code on Takeovers and Mergers ("City
Code"); and the Singapore Code on Takeovers and Mergers (the "Singapore Code")
(collectively the "Takeover Codes") do not apply to the Company as it is
incorporated in the Republic of Singapore and has its operations in China. Any
takeover of the Company therefore will be unregulated by UK takeover
authorities. The Articles of Association do however contain certain takeover
protections which the Board will enforce if any offer is made for the Company.
A copy of the Company's Articles of Association can be viewed on the Company's
website at http://www.chinamedstargroup.com/.
The Company also confirms it has 27,564,138 ordinary shares in issue and has
outstanding 872,853 options (save for options granted to certain of the
Company's advisors at the time of the IPO) to acquire ordinary shares.
A further announcement will be made in due course.
2 May 2008
Enquiries:
China Medstar Ltd Tel: +86 (10) 5825 6867
Dr Cheng Zheng, Chairman and CEO
Yap Yaw Kong, CFO
Evolution Securities Tel: +44 (0) 20 7071 4300
Tom Price/Bobbie Hilliam
Evolution Securities China Tel: +44 (0) 20 7220 4850
Nick Martin
Nexus Financial Ltd Tel: +44 (0) 20 7451 7050
Nicholas Nelson/Kathy Boate
END
1 Year China Med Chart |
1 Month China Med Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
